nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—Disease progression—Telbivudine—hepatitis B	0.0252	0.0893	CcSEcCtD
Crizotinib—Localised oedema—Lamivudine—hepatitis B	0.0123	0.0435	CcSEcCtD
Crizotinib—Hypophosphataemia—Adefovir Dipivoxil—hepatitis B	0.0112	0.0398	CcSEcCtD
Crizotinib—Transaminases increased—Entecavir—hepatitis B	0.011	0.039	CcSEcCtD
Crizotinib—LYN—blood plasma—hepatitis B	0.00637	0.026	CbGeAlD
Crizotinib—FLT3—blood plasma—hepatitis B	0.00545	0.0222	CbGeAlD
Crizotinib—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.00543	0.0192	CcSEcCtD
Crizotinib—Hepatic failure—Entecavir—hepatitis B	0.00541	0.0192	CcSEcCtD
Crizotinib—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00528	0.0187	CcSEcCtD
Crizotinib—PTK2B—blood plasma—hepatitis B	0.00496	0.0202	CbGeAlD
Crizotinib—Sepsis—Telbivudine—hepatitis B	0.00478	0.0169	CcSEcCtD
Crizotinib—MAP3K2—blood plasma—hepatitis B	0.00466	0.019	CbGeAlD
Crizotinib—PTK2—blood plasma—hepatitis B	0.00457	0.0186	CbGeAlD
Crizotinib—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00419	0.0148	CcSEcCtD
Crizotinib—JAK2—blood plasma—hepatitis B	0.00413	0.0168	CbGeAlD
Crizotinib—Neutropenia—Entecavir—hepatitis B	0.00393	0.0139	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Entecavir—hepatitis B	0.00391	0.0138	CcSEcCtD
Crizotinib—NEK9—blood—hepatitis B	0.00378	0.0154	CbGeAlD
Crizotinib—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00371	0.0131	CcSEcCtD
Crizotinib—STK10—blood plasma—hepatitis B	0.00364	0.0149	CbGeAlD
Crizotinib—TAOK3—blood plasma—hepatitis B	0.00363	0.0148	CbGeAlD
Crizotinib—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.0036	0.0127	CcSEcCtD
Crizotinib—Hepatobiliary disease—Entecavir—hepatitis B	0.00354	0.0125	CcSEcCtD
Crizotinib—SRC—blood plasma—hepatitis B	0.00353	0.0144	CbGeAlD
Crizotinib—Muscular weakness—Telbivudine—hepatitis B	0.00352	0.0125	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00352	0.0125	CcSEcCtD
Crizotinib—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00346	0.0122	CcSEcCtD
Crizotinib—LIMK1—blood—hepatitis B	0.0034	0.0139	CbGeAlD
Crizotinib—PRKD3—blood—hepatitis B	0.00332	0.0135	CbGeAlD
Crizotinib—Oedema peripheral—Entecavir—hepatitis B	0.00331	0.0117	CcSEcCtD
Crizotinib—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00324	0.0115	CcSEcCtD
Crizotinib—Neutropenia—Telbivudine—hepatitis B	0.00323	0.0114	CcSEcCtD
Crizotinib—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00322	0.0114	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00321	0.0114	CcSEcCtD
Crizotinib—BLK—blood—hepatitis B	0.0032	0.0131	CbGeAlD
Crizotinib—CSF1R—blood plasma—hepatitis B	0.00317	0.0129	CbGeAlD
Crizotinib—MAPK7—blood—hepatitis B	0.00306	0.0125	CbGeAlD
Crizotinib—TXK—blood—hepatitis B	0.00306	0.0125	CbGeAlD
Crizotinib—FES—blood—hepatitis B	0.00303	0.0124	CbGeAlD
Crizotinib—Neuropathy peripheral—Telbivudine—hepatitis B	0.00302	0.0107	CcSEcCtD
Crizotinib—NEK9—liver—hepatitis B	0.00296	0.0121	CbGeAlD
Crizotinib—Malnutrition—Entecavir—hepatitis B	0.00293	0.0104	CcSEcCtD
Crizotinib—Photophobia—Lamivudine—hepatitis B	0.00291	0.0103	CcSEcCtD
Crizotinib—Neuropathy—Lamivudine—hepatitis B	0.00291	0.0103	CcSEcCtD
Crizotinib—Hepatobiliary disease—Telbivudine—hepatitis B	0.00291	0.0103	CcSEcCtD
Crizotinib—MET—blood—hepatitis B	0.00287	0.0117	CbGeAlD
Crizotinib—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00286	0.0101	CcSEcCtD
Crizotinib—TAOK2—blood—hepatitis B	0.00275	0.0112	CbGeAlD
Crizotinib—Hypoaesthesia—Telbivudine—hepatitis B	0.00275	0.00974	CcSEcCtD
Crizotinib—Sepsis—Lamivudine—hepatitis B	0.00269	0.00953	CcSEcCtD
Crizotinib—SIK2—liver—hepatitis B	0.00266	0.0109	CbGeAlD
Crizotinib—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00264	0.00935	CcSEcCtD
Crizotinib—Leukopenia—Entecavir—hepatitis B	0.00262	0.00928	CcSEcCtD
Crizotinib—PRKD3—liver—hepatitis B	0.00259	0.0106	CbGeAlD
Crizotinib—JAK3—blood—hepatitis B	0.00253	0.0103	CbGeAlD
Crizotinib—PLK4—blood—hepatitis B	0.0025	0.0102	CbGeAlD
Crizotinib—Mediastinal disorder—Telbivudine—hepatitis B	0.00249	0.00882	CcSEcCtD
Crizotinib—STK4—blood—hepatitis B	0.00248	0.0101	CbGeAlD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00248	0.00877	CcSEcCtD
Crizotinib—CASK—liver—hepatitis B	0.00247	0.0101	CbGeAlD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00242	0.00855	CcSEcCtD
Crizotinib—Malnutrition—Telbivudine—hepatitis B	0.00241	0.00852	CcSEcCtD
Crizotinib—AURKA—Floxuridine—Telbivudine—hepatitis B	0.00239	0.263	CbGdCrCtD
Crizotinib—Infection—Entecavir—hepatitis B	0.00237	0.00841	CcSEcCtD
Crizotinib—FES—liver—hepatitis B	0.00237	0.00968	CbGeAlD
Crizotinib—Dysgeusia—Telbivudine—hepatitis B	0.00236	0.00834	CcSEcCtD
Crizotinib—FER—blood—hepatitis B	0.00235	0.00957	CbGeAlD
Crizotinib—ALK—blood—hepatitis B	0.00235	0.00957	CbGeAlD
Crizotinib—Nervous system disorder—Entecavir—hepatitis B	0.00234	0.0083	CcSEcCtD
Crizotinib—LYN—blood—hepatitis B	0.00233	0.00952	CbGeAlD
Crizotinib—Skin disorder—Entecavir—hepatitis B	0.00232	0.00822	CcSEcCtD
Crizotinib—TNK1—blood—hepatitis B	0.00232	0.00947	CbGeAlD
Crizotinib—MAP4K1—blood—hepatitis B	0.0023	0.00938	CbGeAlD
Crizotinib—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00229	0.0081	CcSEcCtD
Crizotinib—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00227	0.00802	CcSEcCtD
Crizotinib—IGF1R—blood—hepatitis B	0.00225	0.0092	CbGeAlD
Crizotinib—MET—liver—hepatitis B	0.00224	0.00915	CbGeAlD
Crizotinib—MAP4K2—blood—hepatitis B	0.00222	0.00907	CbGeAlD
Crizotinib—STK3—blood—hepatitis B	0.00219	0.00894	CbGeAlD
Crizotinib—AURKA—Cladribine—Entecavir—hepatitis B	0.00218	0.24	CbGdCrCtD
Crizotinib—CDK7—liver—hepatitis B	0.00217	0.00885	CbGeAlD
Crizotinib—TAOK2—liver—hepatitis B	0.00215	0.00878	CbGeAlD
Crizotinib—AURKA—blood—hepatitis B	0.00214	0.00872	CbGeAlD
Crizotinib—TESK1—blood—hepatitis B	0.00212	0.00865	CbGeAlD
Crizotinib—Dyspepsia—Entecavir—hepatitis B	0.0021	0.00745	CcSEcCtD
Crizotinib—ACVR1B—liver—hepatitis B	0.00207	0.00846	CbGeAlD
Crizotinib—Gastrointestinal disorder—Entecavir—hepatitis B	0.00206	0.00731	CcSEcCtD
Crizotinib—MERTK—blood—hepatitis B	0.00206	0.00841	CbGeAlD
Crizotinib—Fatigue—Entecavir—hepatitis B	0.00206	0.0073	CcSEcCtD
Crizotinib—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00205	0.00727	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00203	0.0072	CcSEcCtD
Crizotinib—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00203	0.00718	CcSEcCtD
Crizotinib—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00203	0.00718	CcSEcCtD
Crizotinib—LIMK2—blood—hepatitis B	0.00202	0.00823	CbGeAlD
Crizotinib—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00201	0.00713	CcSEcCtD
Crizotinib—NUAK2—blood—hepatitis B	0.00201	0.0082	CbGeAlD
Crizotinib—MAP3K12—blood—hepatitis B	0.00199	0.00814	CbGeAlD
Crizotinib—FLT3—blood—hepatitis B	0.00199	0.00814	CbGeAlD
Crizotinib—ACVR1—blood—hepatitis B	0.00199	0.00814	CbGeAlD
Crizotinib—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00199	0.00703	CcSEcCtD
Crizotinib—Muscular weakness—Lamivudine—hepatitis B	0.00199	0.00703	CcSEcCtD
Crizotinib—STK4—liver—hepatitis B	0.00194	0.00792	CbGeAlD
Crizotinib—Nervous system disorder—Telbivudine—hepatitis B	0.00193	0.00682	CcSEcCtD
Crizotinib—Skin disorder—Telbivudine—hepatitis B	0.00191	0.00675	CcSEcCtD
Crizotinib—ABL2—blood—hepatitis B	0.0019	0.00777	CbGeAlD
Crizotinib—Body temperature increased—Entecavir—hepatitis B	0.00189	0.00669	CcSEcCtD
Crizotinib—BMP2K—blood—hepatitis B	0.00188	0.00767	CbGeAlD
Crizotinib—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00184	0.00653	CcSEcCtD
Crizotinib—FER—liver—hepatitis B	0.00183	0.00748	CbGeAlD
Crizotinib—LYN—liver—hepatitis B	0.00183	0.00745	CbGeAlD
Crizotinib—Neutropenia—Lamivudine—hepatitis B	0.00182	0.00644	CcSEcCtD
Crizotinib—PTK2B—blood—hepatitis B	0.00182	0.00741	CbGeAlD
Crizotinib—TNK1—liver—hepatitis B	0.00182	0.00741	CbGeAlD
Crizotinib—AURKA—Cladribine—Telbivudine—hepatitis B	0.00181	0.199	CbGdCrCtD
Crizotinib—RIPK2—blood—hepatitis B	0.0018	0.00735	CbGeAlD
Crizotinib—Paraesthesia—Telbivudine—hepatitis B	0.00176	0.00624	CcSEcCtD
Crizotinib—TNK2—liver—hepatitis B	0.00176	0.00719	CbGeAlD
Crizotinib—IGF1R—liver—hepatitis B	0.00176	0.00719	CbGeAlD
Crizotinib—EPHA4—blood—hepatitis B	0.00174	0.00711	CbGeAlD
Crizotinib—MAP4K2—liver—hepatitis B	0.00174	0.00709	CbGeAlD
Crizotinib—Dyspepsia—Telbivudine—hepatitis B	0.00173	0.00612	CcSEcCtD
Crizotinib—Asthenia—Entecavir—hepatitis B	0.00172	0.00607	CcSEcCtD
Crizotinib—STK3—liver—hepatitis B	0.00171	0.00699	CbGeAlD
Crizotinib—TIE1—liver—hepatitis B	0.00171	0.00699	CbGeAlD
Crizotinib—MAP3K2—blood—hepatitis B	0.00171	0.00697	CbGeAlD
Crizotinib—Neuropathy peripheral—Lamivudine—hepatitis B	0.0017	0.00602	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Telbivudine—hepatitis B	0.0017	0.006	CcSEcCtD
Crizotinib—Fatigue—Telbivudine—hepatitis B	0.00169	0.00599	CcSEcCtD
Crizotinib—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00167	0.00592	CcSEcCtD
Crizotinib—PTK2—blood—hepatitis B	0.00167	0.00682	CbGeAlD
Crizotinib—TBK1—blood—hepatitis B	0.00167	0.00682	CbGeAlD
Crizotinib—AURKA—liver—hepatitis B	0.00167	0.00682	CbGeAlD
Crizotinib—TYK2—blood—hepatitis B	0.00166	0.00678	CbGeAlD
Crizotinib—TESK1—liver—hepatitis B	0.00166	0.00676	CbGeAlD
Crizotinib—Hepatobiliary disease—Lamivudine—hepatitis B	0.00164	0.00581	CcSEcCtD
Crizotinib—IRAK1—blood—hepatitis B	0.00164	0.00669	CbGeAlD
Crizotinib—Diarrhoea—Entecavir—hepatitis B	0.00164	0.00579	CcSEcCtD
Crizotinib—MERTK—liver—hepatitis B	0.00161	0.00658	CbGeAlD
Crizotinib—RPS6KB1—blood—hepatitis B	0.00161	0.00657	CbGeAlD
Crizotinib—FGR—blood—hepatitis B	0.0016	0.00653	CbGeAlD
Crizotinib—LCK—blood—hepatitis B	0.0016	0.00653	CbGeAlD
Crizotinib—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.0016	0.00565	CcSEcCtD
Crizotinib—Dizziness—Entecavir—hepatitis B	0.00158	0.0056	CcSEcCtD
Crizotinib—LIMK2—liver—hepatitis B	0.00158	0.00643	CbGeAlD
Crizotinib—NUAK2—liver—hepatitis B	0.00157	0.00641	CbGeAlD
Crizotinib—MAP3K12—liver—hepatitis B	0.00156	0.00636	CbGeAlD
Crizotinib—ACVR1—liver—hepatitis B	0.00156	0.00636	CbGeAlD
Crizotinib—FLT3—liver—hepatitis B	0.00156	0.00636	CbGeAlD
Crizotinib—Body temperature increased—Telbivudine—hepatitis B	0.00155	0.0055	CcSEcCtD
Crizotinib—Hypoaesthesia—Lamivudine—hepatitis B	0.00155	0.00549	CcSEcCtD
Crizotinib—SLK—blood—hepatitis B	0.00153	0.00626	CbGeAlD
Crizotinib—STK35—liver—hepatitis B	0.00153	0.00623	CbGeAlD
Crizotinib—EPHB4—blood—hepatitis B	0.00152	0.00621	CbGeAlD
Crizotinib—Vomiting—Entecavir—hepatitis B	0.00152	0.00538	CcSEcCtD
Crizotinib—JAK2—blood—hepatitis B	0.00151	0.00617	CbGeAlD
Crizotinib—Rash—Entecavir—hepatitis B	0.00151	0.00534	CcSEcCtD
Crizotinib—Dermatitis—Entecavir—hepatitis B	0.00151	0.00533	CcSEcCtD
Crizotinib—EPHA2—blood—hepatitis B	0.00149	0.00609	CbGeAlD
Crizotinib—ABL2—liver—hepatitis B	0.00149	0.00608	CbGeAlD
Crizotinib—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00148	0.00525	CcSEcCtD
Crizotinib—BMP2K—liver—hepatitis B	0.00147	0.006	CbGeAlD
Crizotinib—Rash—Adefovir Dipivoxil—hepatitis B	0.00147	0.00521	CcSEcCtD
Crizotinib—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00147	0.0052	CcSEcCtD
Crizotinib—CYP3A5—blood plasma—hepatitis B	0.00147	0.00599	CbGeAlD
Crizotinib—TEK—blood—hepatitis B	0.00146	0.00594	CbGeAlD
Crizotinib—MAP4K5—blood—hepatitis B	0.00146	0.00594	CbGeAlD
Crizotinib—MAP3K3—blood—hepatitis B	0.00146	0.00594	CbGeAlD
Crizotinib—PTK2B—liver—hepatitis B	0.00142	0.0058	CbGeAlD
Crizotinib—Nausea—Entecavir—hepatitis B	0.00142	0.00503	CcSEcCtD
Crizotinib—AURKA—Gemcitabine—Lamivudine—hepatitis B	0.00142	0.156	CbGdCrCtD
Crizotinib—RIPK2—liver—hepatitis B	0.00141	0.00575	CbGeAlD
Crizotinib—Asthenia—Telbivudine—hepatitis B	0.00141	0.00499	CcSEcCtD
Crizotinib—Mediastinal disorder—Lamivudine—hepatitis B	0.0014	0.00497	CcSEcCtD
Crizotinib—EPHB6—blood—hepatitis B	0.00139	0.00568	CbGeAlD
Crizotinib—Nausea—Adefovir Dipivoxil—hepatitis B	0.00139	0.0049	CcSEcCtD
Crizotinib—Malnutrition—Lamivudine—hepatitis B	0.00136	0.0048	CcSEcCtD
Crizotinib—YES1—blood—hepatitis B	0.00135	0.00549	CbGeAlD
Crizotinib—Diarrhoea—Telbivudine—hepatitis B	0.00134	0.00476	CcSEcCtD
Crizotinib—MAP3K2—liver—hepatitis B	0.00134	0.00545	CbGeAlD
Crizotinib—STK10—blood—hepatitis B	0.00133	0.00544	CbGeAlD
Crizotinib—TAOK3—blood—hepatitis B	0.00133	0.00542	CbGeAlD
Crizotinib—Dysgeusia—Lamivudine—hepatitis B	0.00133	0.0047	CcSEcCtD
Crizotinib—TBK1—liver—hepatitis B	0.00131	0.00534	CbGeAlD
Crizotinib—PTK2—liver—hepatitis B	0.00131	0.00534	CbGeAlD
Crizotinib—AURKA—Cytarabine—Lamivudine—hepatitis B	0.0013	0.143	CbGdCrCtD
Crizotinib—TYK2—liver—hepatitis B	0.0013	0.0053	CbGeAlD
Crizotinib—Dizziness—Telbivudine—hepatitis B	0.0013	0.0046	CcSEcCtD
Crizotinib—SRC—blood—hepatitis B	0.00129	0.00528	CbGeAlD
Crizotinib—IRAK1—liver—hepatitis B	0.00128	0.00523	CbGeAlD
Crizotinib—RPS6KB1—liver—hepatitis B	0.00126	0.00513	CbGeAlD
Crizotinib—Anaemia—Lamivudine—hepatitis B	0.00125	0.00444	CcSEcCtD
Crizotinib—FGR—liver—hepatitis B	0.00125	0.0051	CbGeAlD
Crizotinib—LCK—liver—hepatitis B	0.00125	0.0051	CbGeAlD
Crizotinib—Vomiting—Telbivudine—hepatitis B	0.00125	0.00442	CcSEcCtD
Crizotinib—AXL—liver—hepatitis B	0.00125	0.00508	CbGeAlD
Crizotinib—Rash—Telbivudine—hepatitis B	0.00124	0.00438	CcSEcCtD
Crizotinib—Dermatitis—Telbivudine—hepatitis B	0.00124	0.00438	CcSEcCtD
Crizotinib—Syncope—Lamivudine—hepatitis B	0.00122	0.00431	CcSEcCtD
Crizotinib—Leukopenia—Lamivudine—hepatitis B	0.00121	0.0043	CcSEcCtD
Crizotinib—SLK—liver—hepatitis B	0.0012	0.00489	CbGeAlD
Crizotinib—Loss of consciousness—Lamivudine—hepatitis B	0.00119	0.00422	CcSEcCtD
Crizotinib—EPHB4—liver—hepatitis B	0.00119	0.00486	CbGeAlD
Crizotinib—JAK2—liver—hepatitis B	0.00118	0.00482	CbGeAlD
Crizotinib—EPHA2—liver—hepatitis B	0.00117	0.00476	CbGeAlD
Crizotinib—Nausea—Telbivudine—hepatitis B	0.00117	0.00413	CcSEcCtD
Crizotinib—CSF1R—blood—hepatitis B	0.00116	0.00474	CbGeAlD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00115	0.00406	CcSEcCtD
Crizotinib—MAP3K3—liver—hepatitis B	0.00114	0.00465	CbGeAlD
Crizotinib—TEK—liver—hepatitis B	0.00114	0.00465	CbGeAlD
Crizotinib—MAP4K5—liver—hepatitis B	0.00114	0.00465	CbGeAlD
Crizotinib—Oedema—Lamivudine—hepatitis B	0.00111	0.00392	CcSEcCtD
Crizotinib—CYP3A4—blood plasma—hepatitis B	0.0011	0.00449	CbGeAlD
Crizotinib—Infection—Lamivudine—hepatitis B	0.0011	0.00389	CcSEcCtD
Crizotinib—Shock—Lamivudine—hepatitis B	0.00109	0.00385	CcSEcCtD
Crizotinib—Nervous system disorder—Lamivudine—hepatitis B	0.00109	0.00384	CcSEcCtD
Crizotinib—Skin disorder—Lamivudine—hepatitis B	0.00107	0.00381	CcSEcCtD
Crizotinib—YES1—liver—hepatitis B	0.00105	0.00429	CbGeAlD
Crizotinib—STK10—liver—hepatitis B	0.00104	0.00425	CbGeAlD
Crizotinib—TAOK3—liver—hepatitis B	0.00104	0.00424	CbGeAlD
Crizotinib—SRC—liver—hepatitis B	0.00101	0.00413	CbGeAlD
Crizotinib—Paraesthesia—Lamivudine—hepatitis B	0.000994	0.00352	CcSEcCtD
Crizotinib—Dyspnoea—Lamivudine—hepatitis B	0.000987	0.00349	CcSEcCtD
Crizotinib—Dyspepsia—Lamivudine—hepatitis B	0.000974	0.00345	CcSEcCtD
Crizotinib—Decreased appetite—Lamivudine—hepatitis B	0.000962	0.00341	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000955	0.00338	CcSEcCtD
Crizotinib—Fatigue—Lamivudine—hepatitis B	0.000954	0.00338	CcSEcCtD
Crizotinib—Constipation—Lamivudine—hepatitis B	0.000946	0.00335	CcSEcCtD
Crizotinib—ABL1—blood—hepatitis B	0.000919	0.00375	CbGeAlD
Crizotinib—CSF1R—liver—hepatitis B	0.000909	0.00371	CbGeAlD
Crizotinib—Body temperature increased—Lamivudine—hepatitis B	0.000875	0.0031	CcSEcCtD
Crizotinib—Asthenia—Lamivudine—hepatitis B	0.000794	0.00281	CcSEcCtD
Crizotinib—ABCB1—blood plasma—hepatitis B	0.00078	0.00318	CbGeAlD
Crizotinib—Diarrhoea—Lamivudine—hepatitis B	0.000757	0.00268	CcSEcCtD
Crizotinib—Dizziness—Lamivudine—hepatitis B	0.000732	0.00259	CcSEcCtD
Crizotinib—ABL1—liver—hepatitis B	0.000718	0.00293	CbGeAlD
Crizotinib—Vomiting—Lamivudine—hepatitis B	0.000704	0.00249	CcSEcCtD
Crizotinib—Rash—Lamivudine—hepatitis B	0.000698	0.00247	CcSEcCtD
Crizotinib—Dermatitis—Lamivudine—hepatitis B	0.000697	0.00247	CcSEcCtD
Crizotinib—Nausea—Lamivudine—hepatitis B	0.000657	0.00233	CcSEcCtD
Crizotinib—CYP3A5—blood—hepatitis B	0.000538	0.00219	CbGeAlD
Crizotinib—CYP3A5—liver—hepatitis B	0.000421	0.00172	CbGeAlD
Crizotinib—CYP3A4—blood—hepatitis B	0.000404	0.00165	CbGeAlD
Crizotinib—CYP3A4—liver—hepatitis B	0.000316	0.00129	CbGeAlD
Crizotinib—ABCB1—blood—hepatitis B	0.000286	0.00117	CbGeAlD
Crizotinib—ABCB1—liver—hepatitis B	0.000223	0.000911	CbGeAlD
Crizotinib—IRAK1—Immune System—PTEN—hepatitis B	1.12e-05	2.42e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—CTNNB1—hepatitis B	1.12e-05	2.41e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—NFKB1—hepatitis B	1.12e-05	2.41e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—CDKN1A—hepatitis B	1.11e-05	2.4e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—F2—hepatitis B	1.11e-05	2.4e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—PTEN—hepatitis B	1.11e-05	2.39e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CXCL10—hepatitis B	1.11e-05	2.39e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GOT2—hepatitis B	1.11e-05	2.39e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—NFKB1—hepatitis B	1.1e-05	2.38e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—CDKN1A—hepatitis B	1.1e-05	2.38e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—PTEN—hepatitis B	1.1e-05	2.37e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—NFKB1—hepatitis B	1.09e-05	2.36e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—CDKN1A—hepatitis B	1.09e-05	2.36e-05	CbGpPWpGaD
Crizotinib—SRC—Axon guidance—IL6—hepatitis B	1.09e-05	2.35e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—PTEN—hepatitis B	1.09e-05	2.35e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—CCR5—hepatitis B	1.09e-05	2.35e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—NFKB1—hepatitis B	1.08e-05	2.34e-05	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	1.07e-05	2.32e-05	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—TP53—hepatitis B	1.07e-05	2.32e-05	CbGpPWpGaD
Crizotinib—JAK3—Immune System—IL6—hepatitis B	1.07e-05	2.31e-05	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—IL6—hepatitis B	1.07e-05	2.31e-05	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—IL6—hepatitis B	1.07e-05	2.3e-05	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—IL6—hepatitis B	1.06e-05	2.29e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—HLA-A—hepatitis B	1.06e-05	2.29e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—CDKN1A—hepatitis B	1.06e-05	2.28e-05	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—IL2—hepatitis B	1.06e-05	2.28e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—PTEN—hepatitis B	1.06e-05	2.28e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IFNG—hepatitis B	1.06e-05	2.28e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—IL2—hepatitis B	1.05e-05	2.27e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—NFKB1—hepatitis B	1.05e-05	2.27e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IFNG—hepatitis B	1.05e-05	2.27e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—TLR4—hepatitis B	1.05e-05	2.27e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CCR5—hepatitis B	1.05e-05	2.26e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-DRB1—hepatitis B	1.05e-05	2.26e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—TP53—hepatitis B	1.05e-05	2.26e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—NOS2—hepatitis B	1.04e-05	2.25e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—IL2—hepatitis B	1.04e-05	2.23e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—CTNNB1—hepatitis B	1.03e-05	2.23e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TGFB1—hepatitis B	1.03e-05	2.23e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—TP53—hepatitis B	1.02e-05	2.21e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CD4—hepatitis B	1.02e-05	2.2e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD4—hepatitis B	1.01e-05	2.19e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—CTNNB1—hepatitis B	1.01e-05	2.19e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—TGFB1—hepatitis B	1.01e-05	2.18e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—CDKN1A—hepatitis B	1.01e-05	2.18e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—PTEN—hepatitis B	1.01e-05	2.17e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—IL6—hepatitis B	1e-05	2.16e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—CTNNB1—hepatitis B	9.99e-06	2.16e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—IL2—hepatitis B	9.91e-06	2.14e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—CDKN1A—hepatitis B	9.91e-06	2.14e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—PTEN—hepatitis B	9.88e-06	2.13e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IFNG—hepatitis B	9.87e-06	2.13e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—NFKB1—hepatitis B	9.84e-06	2.12e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CCR5—hepatitis B	9.82e-06	2.12e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CXCL10—hepatitis B	9.82e-06	2.12e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—AKR1B1—hepatitis B	9.8e-06	2.12e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—CDKN1A—hepatitis B	9.76e-06	2.11e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—PTEN—hepatitis B	9.74e-06	2.1e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—NFKB1—hepatitis B	9.69e-06	2.09e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TNF—hepatitis B	9.63e-06	2.08e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—IL2—hepatitis B	9.61e-06	2.07e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—IL2—hepatitis B	9.6e-06	2.07e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—IL6—hepatitis B	9.58e-06	2.07e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—CTNNB1—hepatitis B	9.57e-06	2.06e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GGT1—hepatitis B	9.56e-06	2.06e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GOT1—hepatitis B	9.56e-06	2.06e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—IL6—hepatitis B	9.55e-06	2.06e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD4—hepatitis B	9.54e-06	2.06e-05	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—IL6—hepatitis B	9.46e-06	2.04e-05	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—IL6—hepatitis B	9.42e-06	2.03e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—IL6—hepatitis B	9.41e-06	2.03e-05	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—TP53—hepatitis B	9.41e-06	2.03e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GGT2—hepatitis B	9.4e-06	2.03e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—IL6—hepatitis B	9.38e-06	2.02e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL2—hepatitis B	9.38e-06	2.02e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—CDKN1A—hepatitis B	9.34e-06	2.02e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL2—hepatitis B	9.33e-06	2.01e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—PTEN—hepatitis B	9.32e-06	2.01e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—NFKB1—hepatitis B	9.28e-06	2e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CTNNB1—hepatitis B	9.28e-06	2e-05	CbGpPWpGaD
Crizotinib—CDK7—Disease—IL6—hepatitis B	9.24e-06	2e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CYP2A6—hepatitis B	9.24e-06	2e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—NOS2—hepatitis B	9.22e-06	1.99e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TGFB1—hepatitis B	9.19e-06	1.98e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—IL6—hepatitis B	9.19e-06	1.98e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—IL6—hepatitis B	9.16e-06	1.98e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CDKN1A—hepatitis B	9.06e-06	1.96e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CTNNB1—hepatitis B	9.05e-06	1.95e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—PTEN—hepatitis B	9.04e-06	1.95e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CTNNB1—hepatitis B	9.01e-06	1.94e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—F2—hepatitis B	9e-06	1.94e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—NFKB1—hepatitis B	9e-06	1.94e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—IL6—hepatitis B	8.85e-06	1.91e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CDKN1A—hepatitis B	8.84e-06	1.91e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—PTEN—hepatitis B	8.82e-06	1.9e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—CD4—hepatitis B	8.8e-06	1.9e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CDKN1A—hepatitis B	8.8e-06	1.9e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—PTEN—hepatitis B	8.78e-06	1.9e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—NFKB1—hepatitis B	8.78e-06	1.89e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL2—hepatitis B	8.77e-06	1.89e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—NFKB1—hepatitis B	8.74e-06	1.89e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—IFNG—hepatitis B	8.65e-06	1.87e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCR5—hepatitis B	8.6e-06	1.86e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CTNNB1—hepatitis B	8.47e-06	1.83e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—F2—hepatitis B	8.42e-06	1.82e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GOT2—hepatitis B	8.36e-06	1.8e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD4—hepatitis B	8.35e-06	1.8e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—TGFB1—hepatitis B	8.34e-06	1.8e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—TP53—hepatitis B	8.33e-06	1.8e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CDKN1A—hepatitis B	8.27e-06	1.79e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—PTEN—hepatitis B	8.26e-06	1.78e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL2—hepatitis B	8.24e-06	1.78e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—NFKB1—hepatitis B	8.22e-06	1.77e-05	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	8.19e-06	1.77e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TGFB1—hepatitis B	8.19e-06	1.77e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL2—hepatitis B	8.13e-06	1.75e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TGFB1—hepatitis B	8.08e-06	1.74e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CTNNB1—hepatitis B	7.96e-06	1.72e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CTNNB1—hepatitis B	7.85e-06	1.69e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—CTNNB1—hepatitis B	7.82e-06	1.69e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—IL6—hepatitis B	7.77e-06	1.68e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CDKN1A—hepatitis B	7.77e-06	1.68e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—PTEN—hepatitis B	7.76e-06	1.67e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—IL6—hepatitis B	7.76e-06	1.67e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TGFB1—hepatitis B	7.73e-06	1.67e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—NFKB1—hepatitis B	7.72e-06	1.67e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—CD4—hepatitis B	7.71e-06	1.66e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL2—hepatitis B	7.71e-06	1.66e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL2—hepatitis B	7.68e-06	1.66e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CDKN1A—hepatitis B	7.67e-06	1.65e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—IFNG—hepatitis B	7.66e-06	1.65e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—PTEN—hepatitis B	7.65e-06	1.65e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—CDKN1A—hepatitis B	7.64e-06	1.65e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—PTEN—hepatitis B	7.62e-06	1.65e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCR5—hepatitis B	7.61e-06	1.64e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—NFKB1—hepatitis B	7.61e-06	1.64e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TP53—hepatitis B	7.57e-06	1.63e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TGFB1—hepatitis B	7.49e-06	1.62e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IL6—hepatitis B	7.49e-06	1.62e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL2—hepatitis B	7.49e-06	1.62e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—IL6—hepatitis B	7.45e-06	1.61e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CTNNB1—hepatitis B	7.44e-06	1.61e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CTNNB1—hepatitis B	7.42e-06	1.6e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD4—hepatitis B	7.39e-06	1.6e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—IL6—hepatitis B	7.39e-06	1.6e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—F2—hepatitis B	7.38e-06	1.59e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CDKN1A—hepatitis B	7.27e-06	1.57e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—PTEN—hepatitis B	7.25e-06	1.57e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CDKN1A—hepatitis B	7.25e-06	1.56e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—PTEN—hepatitis B	7.23e-06	1.56e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CTNNB1—hepatitis B	7.23e-06	1.56e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NFKB1—hepatitis B	7.22e-06	1.56e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GOT1—hepatitis B	7.22e-06	1.56e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GGT1—hepatitis B	7.22e-06	1.56e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—NFKB1—hepatitis B	7.2e-06	1.55e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CDKN1A—hepatitis B	7.06e-06	1.52e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—PTEN—hepatitis B	7.04e-06	1.52e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL6—hepatitis B	7.01e-06	1.51e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NFKB1—hepatitis B	7.01e-06	1.51e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—IL6—hepatitis B	6.93e-06	1.5e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—IL6—hepatitis B	6.87e-06	1.48e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—CTNNB1—hepatitis B	6.85e-06	1.48e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—CD4—hepatitis B	6.83e-06	1.47e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL6—hepatitis B	6.8e-06	1.47e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL2—hepatitis B	6.8e-06	1.47e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TP53—hepatitis B	6.75e-06	1.46e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—CDKN1A—hepatitis B	6.69e-06	1.44e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—PTEN—hepatitis B	6.68e-06	1.44e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TP53—hepatitis B	6.65e-06	1.44e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CTNNB1—hepatitis B	6.57e-06	1.42e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—F2—hepatitis B	6.53e-06	1.41e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TGFB1—hepatitis B	6.43e-06	1.39e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CDKN1A—hepatitis B	6.42e-06	1.38e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—PTEN—hepatitis B	6.4e-06	1.38e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—NFKB1—hepatitis B	6.37e-06	1.38e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TP53—hepatitis B	6.36e-06	1.37e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TGFB1—hepatitis B	6.34e-06	1.37e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—TGFB1—hepatitis B	6.32e-06	1.36e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—IL6—hepatitis B	6.28e-06	1.36e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—IL6—hepatitis B	6.17e-06	1.33e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TP53—hepatitis B	6.17e-06	1.33e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—IL6—hepatitis B	6.09e-06	1.31e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—CTNNB1—hepatitis B	6.06e-06	1.31e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL2—hepatitis B	6.06e-06	1.31e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TGFB1—hepatitis B	6.01e-06	1.3e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—CDKN1A—hepatitis B	5.92e-06	1.28e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—PTEN—hepatitis B	5.91e-06	1.28e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CTNNB1—hepatitis B	5.85e-06	1.26e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TGFB1—hepatitis B	5.84e-06	1.26e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—IL6—hepatitis B	5.82e-06	1.26e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CDKN1A—hepatitis B	5.72e-06	1.23e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—PTEN—hepatitis B	5.7e-06	1.23e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP2A6—hepatitis B	5.69e-06	1.23e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NFKB1—hepatitis B	5.68e-06	1.23e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL2—hepatitis B	5.67e-06	1.22e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—IL6—hepatitis B	5.65e-06	1.22e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—IL6—hepatitis B	5.64e-06	1.22e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—TGFB1—hepatitis B	5.53e-06	1.19e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL6—hepatitis B	5.51e-06	1.19e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL6—hepatitis B	5.49e-06	1.18e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CTNNB1—hepatitis B	5.48e-06	1.18e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CDKN1A—hepatitis B	5.35e-06	1.15e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PTEN—hepatitis B	5.34e-06	1.15e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NFKB1—hepatitis B	5.31e-06	1.15e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TP53—hepatitis B	5.29e-06	1.14e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TP53—hepatitis B	5.22e-06	1.13e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL6—hepatitis B	5.16e-06	1.11e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GOT2—hepatitis B	5.15e-06	1.11e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ALB—hepatitis B	5.09e-06	1.1e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL2—hepatitis B	4.97e-06	1.07e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TP53—hepatitis B	4.95e-06	1.07e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—TGFB1—hepatitis B	4.9e-06	1.06e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL6—hepatitis B	4.85e-06	1.05e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TP53—hepatitis B	4.81e-06	1.04e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CTNNB1—hepatitis B	4.8e-06	1.04e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL6—hepatitis B	4.78e-06	1.03e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—IL6—hepatitis B	4.76e-06	1.03e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TGFB1—hepatitis B	4.73e-06	1.02e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CDKN1A—hepatitis B	4.69e-06	1.01e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PTEN—hepatitis B	4.67e-06	1.01e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NFKB1—hepatitis B	4.65e-06	1e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL6—hepatitis B	4.53e-06	9.78e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL6—hepatitis B	4.52e-06	9.75e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GGT1—hepatitis B	4.45e-06	9.6e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GOT1—hepatitis B	4.45e-06	9.6e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TGFB1—hepatitis B	4.42e-06	9.55e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL6—hepatitis B	4.4e-06	9.5e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL2—hepatitis B	4.4e-06	9.49e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CTNNB1—hepatitis B	4.25e-06	9.17e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—IL6—hepatitis B	4.17e-06	9e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CDKN1A—hepatitis B	4.15e-06	8.95e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PTEN—hepatitis B	4.14e-06	8.93e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NFKB1—hepatitis B	4.12e-06	8.89e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL6—hepatitis B	4e-06	8.63e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TP53—hepatitis B	3.89e-06	8.4e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PTEN—hepatitis B	3.88e-06	8.38e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TGFB1—hepatitis B	3.88e-06	8.37e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ALB—hepatitis B	3.84e-06	8.28e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—IL6—hepatitis B	3.69e-06	7.97e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TP53—hepatitis B	3.64e-06	7.86e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL6—hepatitis B	3.56e-06	7.69e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TGFB1—hepatitis B	3.43e-06	7.41e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL6—hepatitis B	3.33e-06	7.2e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TP53—hepatitis B	3.19e-06	6.89e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTEN—hepatitis B	2.93e-06	6.32e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL6—hepatitis B	2.92e-06	6.3e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TP53—hepatitis B	2.82e-06	6.1e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL6—hepatitis B	2.59e-06	5.58e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALB—hepatitis B	2.36e-06	5.1e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTEN—hepatitis B	1.8e-06	3.89e-06	CbGpPWpGaD
